Phase Ib study of afatinib plus standard-dose cetuximab in patients (pts) with advanced solid tumors.

被引：0
|
作者：
Gazzah, Anas
Boni, Valentina
Soria, Jean-Charles
Holgado, Esther
Even, Caroline
Kaci, Mahmoud Ould
Nazabadioko, Serge
Xue, Wenqiong
Calvo, Emiliano
机构：
[1] Gustave Roussy, Drug Dev Dept, Villejuif, France
[2] Ctr Integral Oncol Clara Campal, START Madrid, Madrid, Spain
[3] Boehringer Ingelheim GmbH & Co KG, Paris, France
[4] Ingelheim Pharmaceut Inc, Ridgefield, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.2536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2536
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase lb study of afatinib plus standard-dose cetuximab in patients with advanced solid tumours
    Gazzah, A.
    Boni, V.
    Soria, J. C.
    Calles, A.
    Even, C.
    Doger, B.
    Mahjoubi, L.
    Bahleda, R.
    Ould-Kaci, M.
    Esler, A.
    Nazabadioko, S.
    Calvo, E.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S139 - S140
  • [2] A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours
    Gazzah, Anas
    Boni, Valentina
    Soria, Jean-Charles
    Calles, Antonio
    Even, Caroline
    Doger, Bernard
    Mahjoubi, Linda
    Bahleda, Rastislav
    Ould-Kaci, Mahmoud
    Esler, Anne
    Nazabadioko, Serge
    Calvo, Emiliano
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 1 - 8
  • [3] A phase I study of afatinib combined with carboplatin or carboplatin plus paclitaxel in patients (pts) with advanced solid tumors.
    Gao, Fangfei
    O'Brien, Mary
    Sarker, Debashis
    Bhosle, Jaishree
    Yap, Timothy Anthony
    Uttenreuther-Fischer, Martina Maria
    Pemberton, Karine
    Goeldner, Rainer-Georg
    Wiebe, Sabrina
    De Bono, Johann S.
    Spicer, James F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors
    Camidge, D. Ross
    Sequist, Lecia, V
    Janne, Pasi A.
    Weickhardt, Andrew J.
    Dowling, Elizabeth S.
    Alicea, Jeanette
    Fan, Jean
    Oxnard, Geoffrey R.
    CLINICAL LUNG CANCER, 2018, 19 (05) : E655 - E665
  • [5] A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours (vol 104, pg 1, 2018)
    Gazzah, Anas
    Boni, Valentina
    Soria, Jean-Charles
    Calles, Antonio
    Even, Caroline
    Doger, Bernard
    Mahjoubi, Linda
    Bahleda, Rastislav
    Ould-Kaci, Mahmoud
    Esler, Anne
    Nazabadioko, Serge
    Calvo, Emiliano
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : 198 - 198
  • [6] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Phase Ib study of axitinib in combination with crizotinib in patients with advanced solid tumors.
    Shepard, Dale Randall
    Bruce, Justine Yang
    Garrido-Laguna, Ignacio
    Rosbrook, Brad
    Martini, Jean-Francols
    Plthavala, Yazdi K.
    Valota, Olga
    Michaelson, M. Dror
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A phase Ib trial of ERK inhibition with ulixertinib combined with palbociclib in patients (Pts) with advanced solid tumors.
    Raybould, Alison L.
    Burgess, Brian
    Urban, Clarissa
    Naim, Rashid
    Lee, Michael Sangmin
    McRee, Autumn Jackson
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Phase IB dose escalation study of bortezomib and sunitinib in patients with refractory solid tumors.
    Kauh, J. S.
    Harvey, R. D.
    Lawson, D. H.
    Owonikoko, T. K.
    Tighiouart, M.
    Ramalingam, S. S.
    Shin, D. M.
    Lewis, C. M.
    El-Rayes, B. F.
    Khuri, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase IB study of eribulin mesylate in combination with carboplatin in patients with advanced solid tumors.
    Swami, U.
    Petrylak, D. P.
    Raftopoulos, H.
    Shuster, D. E.
    Wang, G.
    Kumar, V.
    Martinez, G.
    Goel, S.
    Alsner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345